Health Care Technology


When PharmaJet’s innovative needle-free injection technology received FDA approval, the company tapped Comprise to develop a comprehensive communications plan to generate interest in its proprietary technology, bolster credibility with retailers and pharmacists and establish the PharmaJet brand as the predominant needle-free technology on the market.

doctors discussing lab results image

Our Work

To support PharmaJet’s launch and the significant growth potential for the company’s needle-free technology, the public relations program initially focused on influencing pharmacists, retail pharmacies and other health care professionals through traditional public relations tactics, social media, infographics and blogging.

Following a successful launch, the program focused on content creation through eye-catching and informative infographics, contributed content and other thought leadership opportunities, and drafted and distributed press releases. The program also began developing an engaged social media audience, updating the PharmaJet website and utilizing SEO tactics to ensure users find PharmaJet online.

The Results

In just the first year of our engagement, PharmaJet grew both its Facebook and its LinkedIn communities and increased the number of likes on the company’s YouTube channel. Additionally, our SEO strategy in year one helped PharmaJet attract 130.8% more unique visitors as the company’s pages began climbing in the search engine results pages. With Comprise’s help, PharmaJet secured coverage in pharmacy and health care outlets and national and local publications, including Digital Journal, Everyday Health, Popular Science, Colorado Public Radio, Smithsonian and Washington Post.

Local politicians also found value in PharmaJet’s innovative technology, with CBS’ Denver affiliate station covering a story about Colorado’s governor at the time, John Hickenlooper, receiving a needle-free flu shot from PharmaJet and  Senator Michael Bennet visiting PharmaJet’s headquarters to highlight the need for emergency research funding to combat Zika virus.

The Coverage

Let Us Help

Tell Your Story